We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBSC icon
8501
JPMorgan BetaBuilders US Small Cap Equity ETF
BBSC
$711M
$9K ﹤0.01%
+141
New +$8.54K
CALC icon
8502
CalciMedica
CALC
$11.9M
$9K ﹤0.01%
532
+318
+149% +$6.06K
CANF
8503
Can-Fite BioPharma American Depositary Shares
CANF
$6.79M
$9K ﹤0.01%
+36
New +$8.31K
BNCWW
8504
CEA Industries Inc Warrant
BNCWW
$9K ﹤0.01%
+13,012
New +$6.8K
COCH icon
8505
Envoy Medical
COCH
$53.2M
$9K ﹤0.01%
948
+20
+2% +$195
CODX
8506
Co-Diagnostics
CODX
$5.45M
$9K ﹤0.01%
50
-826
-94% -$171K
CPIX icon
8507
Cumberland Pharmaceuticals
CPIX
$108M
$9K ﹤0.01%
+3,280
New +$10.9K
DAO
8508
Youdao
DAO
$1.96B
$9K ﹤0.01%
1,220
-2,912
-70% -$33.1K
DXR icon
8509
Daxor
DXR
$63.3M
$9K ﹤0.01%
855
+208
+32% +$2.28K
ELUT icon
8510
Elutia
ELUT
$38.3M
$9K ﹤0.01%
1,558
-13
-0.8% -$77
ENSC icon
8511
Ensysce Biosciences
ENSC
$4.3M
$9K ﹤0.01%
2
-1
-33% -$6.61K
FAT
8512
DELISTED
FAT Brands
FAT
$9K ﹤0.01%
2,239
+883
+65% +$4.59K
FCCO icon
8513
First Community Corp
FCCO
$325M
$9K ﹤0.01%
421
-334
-44% -$7.01K
FDHT
8514
DELISTED
Fidelity Digital Health ETF
FDHT
$9K ﹤0.01%
401
+393
+4,913% +$8.73K
GB
8515
DELISTED
Global Blue Group Holding
GB
$9K ﹤0.01%
1,717
-7,919
-82% -$48.8K
HLMN icon
8516
Hillman Solutions
HLMN
$1.63B
$9K ﹤0.01%
799
+200
+33% +$1.97K
HOWL icon
8517
Werewolf Therapeutics
HOWL
$17.9M
$9K ﹤0.01%
2,103
-7,356
-78% -$51.5K
HYBL icon
8518
State Street Blackstone High Income ETF
HYBL
$570M
$9K ﹤0.01%
+299
New +$8.95K
HYIN icon
8519
WisdomTree Private Credit and Alternative Income Fund
HYIN
$51M
$9K ﹤0.01%
377
+296
+365% +$7.05K
INBS icon
8520
Intelligent Bio Solutions
INBS
$4.35M
$9K ﹤0.01%
5
+1
+25% +$2.3K
IVRA
8521
DELISTED
Invesco Real Assets ESG ETF
IVRA
$9K ﹤0.01%
565
-1,670
-75% -$24.9K
KALL
8522
DELISTED
KraneShares MSCI All China Index ETF
KALL
$9K ﹤0.01%
347
-979
-74% -$26.3K
LCTD icon
8523
iShares World ex U.S. Carbon Transition Readiness Aware Active ETF
LCTD
$287M
$9K ﹤0.01%
+200
New +$9.06K
LEXX icon
8524
Lexaria Bioscience
LEXX
$7.85M
$9K ﹤0.01%
178
-98
-36% -$5.54K
NMAD
8525
Nomad Power Solutions
NMAD
$78.6M
$9K ﹤0.01%
732
-19
-3% -$308

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.